Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaMatrix Holdings
Yardley, Pennsylvania, USApharmamatrix.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PharmaMatrix is a pharmaceutical consulting and contract research organization (CRO) that provides strategic and technical expertise in drug development, with a focus on clinical pharmacology and regulatory affairs. The company specializes in pharmacokinetics (PK), pharmacodynamics (PD), and the design and management of Phase 1 and Phase 2 clinical trials. PharmaMatrix assists biotechnology and pharmaceutical companies in navigating the FDA's Investigational New Drug (IND) and New Drug Application (NDA) processes, offering services such as protocol development, data analysis, and quality assurance auditing. The firm is particularly recognized for its expertise in bioequivalence studies and clinical pharmacology strategy.
- Modalities
- Small moleculeBiologic
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on PharmaMatrix Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PharmaMatrix Holdings.